MELISSA MOYERS: Open Payments
NPI 1427398213 · RUSKIN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 23 payments from 11 companies in 2025. Trend: 2023 $198 · 2024 $718 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $96 |
| Exact Sciences Corporation | 4 | $78 |
| Novo Nordisk Inc | 3 | $54 |
| Dynavax Technologies Corporation | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Amgen Inc. | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Lilly USA, LLC | 1 | $26 |
| REVANCE THERAPEUTICS, INC. | 1 | $23 |
Products named: ELIQUIS, Cologuard Collection Kit, Heplisav-B, JARDIANCE, TRELEGY ELLIPTA, Ozempic, OTEZLA, Kerendia.
Industry payments across FL — which companies pay providers there.
